Postpartum depression is a serious condition that affects millions of new moms each year, and many healthcare professionals recommend depression medication to help combat it. Recent research outlines the importance of treating postpartum depression by highlighting the negative impact that depression can have on mothers and their infants.
After childbirth, many women experience what’s known as the “baby blues,” but this isn’t the same as postpartum depression because it doesn’t require medication and resolves on its own. Postpartum depression can be diagnosed months after childbirth, lasts for a longer period of time, and involves thought patterns that can be extremely detrimental to the health of both mom and baby. About 1 in 7 new moms experience postpartum depression, and these women are often prescribed medication for the condition.
Untreated maternal depression can have negative effects on babies. Infants and young children whose mothers have untreated depression can show behavioral and cognitive development problems very early in life. Some of these problems include difficulties with self-regulation, difficulties paying attention, poor self-control, a tendency to withdraw, poor coping skills, and problems socializing with others.
For a woman with no history of psychiatric illness, talk therapy is usually the first option for treating postpartum depression, but therapy sometimes isn’t the best option. Talk therapy isn’t available everywhere, can be expensive, takes a certain amount of time to produce results, and isn't always enough treatment on its own. Other times, it’s simply not effective, and another treatment option is needed.
Depression medication is also prescribed to women who don’t have depression but do have another psychiatric illness, including bulimia, panic disorder, generalized anxiety disorder, post-traumatic stress disorder, and obsessive-compulsive disorder.
This means that for a lot of women who have a psychiatric illness or who won’t benefit from therapy or therapy alone, medication is a viable treatment option.
It has been demonstrated that small amounts of depression medication do get passed to newborns through maternal breast milk. Research has shown through measuring the amount of the medication in infant serum - a vital component in an infant’s blood - that small, relatively safe amounts, are present. When weighed against the risk of untreated disease, use of antidepressant medications when needed in breastfeeding mothers is appropriate.
Because there are so many benefits to breastfeeding, and because maternal depression has such a negative impact on infants, experts often recommend the following:
By looking at the number of prescriptions that breastfeeding mothers received while breastfeeding, experts determined that many women actually stop their depression medication while breastfeeding. It’s likely that they do this out of fear that they’ll harm their baby by passing the medication through their breast milk.
These results speak measures about how committed mothers are to keeping their infants safe. But it also shows a worrisome trend in which women discontinue their postpartum depression treatment without realizing that it’s a serious conditions that itself can also affect the infant. The benefits of treating depression significantly outweigh potential risks associated with medication in a mother’s breast milk.
While a woman’s treatment options for depression depend very much on her own individual factors, it is often considered safer for breastfeeding women to treat their depression through medication than to ignore the condition or to stop breastfeeding. So you should talk to your healthcare provider about their opinions on medication for postpartum depression.